NuVox Pharma

Nuvectis Pharma

This biopharmaceutical company develops precision medicines and targeted small molecule therapeutics for patients with advanced cancers and other serious conditions.

Noxxon Pharma

This biotechnology firm develops mirror-image oligonucleotide therapeutics to treat aggressive cancers by targeting the tumour microenvironment for patients and pharmaceutical partners.

HBOX

This company develops respiratory support devices that use hyperbaric blood oxygenation to treat patients with acute lung failure.

Vaporox

This company develops medical devices for healing chronic wounds by delivering concentrated oxygen and water vapor to healthcare facilities and clinics.

Peroxitech

This biopharmaceutical company develops peptide-based therapeutics to treat acute lung injury and other oxidative injury diseases for patients and healthcare providers.

Nuvation Bio

This biopharmaceutical company develops and commercialises targeted oncology therapies for patients with cancers that have unmet medical needs.

Convert Pharmaceuticals

The company develops hypoxia-activated prodrugs that transform into anti-cancer agents to treat patients with solid tumours.

Aeromics

This pharmaceutical company develops an intravenous drug to treat brain swelling in patients suffering from severe ischemic stroke.